Who are NeuroSense Therapeutics Ltd.'s main suppliers?

NeuroSense Therapeutics Ltd. (NRSNW) key suppliers include: ORANY, ORANY, Sanofi, Sanofi. View the full supplier network at chainsifter.com/chain/NRSNW.

Who are NeuroSense Therapeutics Ltd.'s major customers?

NeuroSense Therapeutics Ltd. (NRSNW) key customers include: ORANY, ORANY. View the full customer network at chainsifter.com/chain/NRSNW.

What sector is NeuroSense Therapeutics Ltd. in?

NeuroSense Therapeutics Ltd. (NRSNW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

NeuroSense Therapeutics Ltd. Supplier List (NRSNW): 4 Verified Suppliers

4Suppliers

2Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

NeuroSense Therapeutics Ltd. (NRSNW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

7Total relationships

2Distinct source URLs

1High confidence

0.746Average confidence

2026-10-01Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

NeuroSense Therapeutics Ltd. Suppliers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from NRSNW graph: ilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisd…
ORANY	ORANY	72%	ilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are seeking approval. We currently employ internal resources to …
SNYNF	Sanofi	72%	pivotal trial. We also intend to negotiate back-up supply agreements with other third-party manufacturers for the commercial production of those products. Development and commercial quantities of any…
SNYNF	Sanofi	72%	Reciprocal relationship from SNYNF graph: Reciprocal relationship from NRSNW graph: pivotal trial. We also intend to negotiate back-up supply agreements with other third-party manufacturers for the c…

NeuroSense Therapeutics Ltd. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from NRSNW graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from NRSNW graph: Reciprocal relationship from OR…
ORANY	ORANY	72%	ilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are seeking approval. We currently employ internal resources to …

NeuroSense Therapeutics Ltd. Debt Obligations

Instrument	Description	Confidence	Evidence
NRSNW-DEBT-11369	Warrants outstanding: 3000000	90%	xbrl warrant detail from xbrl 2024-12-31.

NeuroSense Therapeutics Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NeuroSense Therapeutics Ltd..

NeuroSense Therapeutics Ltd. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for NeuroSense Therapeutics Ltd..

NeuroSense Therapeutics Ltd. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SNYNF	Sanofi	100.00	1	['supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
BLRX	BioLineRx Ltd.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
ALXO	ALX Oncology Holdings Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
ANL	Adlai Nortye Ltd.	50.00	2
ANRO	Alto Neuroscience, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
CRVS	Corvus Pharmaceuticals, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2

NeuroSense Therapeutics Ltd. Supply Chain